My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Shankar Musunuri
Recent news which mentions Shankar Musunuri
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
January 13, 2023
Tickers
INNO
Tags
Neuronetics Inc/
David Prohaska
Biotech
From
Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
June 21, 2022
Tags
Coronavirus
Biotech
Ocugen Inc/
From
Business Journals
Ocugen to resume Covaxin trials 'immediately' after FDA lifts its latest clinical hold
May 23, 2022
Tags
Pharmaceuticals
Coronavirus
Biotech
From
Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
April 18, 2022
Tags
Health Care
Marcelo Ebrard
Insurance
From
Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
April 08, 2022
Tickers
INNO
Tags
Ocugen Inc/
Venture capital
Shankar Musunuri
From
Business Journals
FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets
February 18, 2022
Tags
Coronavirus
Biotech
Pharmaceuticals
From
Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
January 27, 2022
Tags
Ocugen Inc/
Pharmaceuticals
Biotech
From
Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
November 05, 2021
Tags
Pharmaceuticals
Ocugen Inc/
Biotech
From
Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
October 29, 2021
Tickers
INNO
Tags
Craig Fraser
Inno
Health Care
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.